![glp-1 based therapeutics summit 3rd GLP-1-Based 2026 [04/14/26] GLP-1 therapy appears to reduce](https://media.thebostoncalendar.com/images/q_auto,fl_lossy/v1764586403/xfhrsgzqsy7gc1nv7hdi/3rd-glp-1-based-therapeutics-summit-2026.jpg)
glp-1 based therapeutics summit 3rd GLP-1-Based 2026 [04/14/26] GLP-1 therapy appears to reduce
Description
doi: 10.1186/s12893-016-0123-8
![glp-1 based therapeutics summit 3rd GLP-1-Based 2026 [04/14/26] GLP-1 therapy appears to reduce](https://lookaside.instagram.com/seo/google_widget/crawler/?media_id=3943943109844364976)
Affiliate relationships do not determine medical suitability, provider approval, safety information, or eligibility
![glp-1 based therapeutics summit 3rd GLP-1-Based 2026 [04/14/26] GLP-1 therapy appears to reduce](https://media.licdn.com/dms/image/v2/D5610AQGqbyif3tY8yg/image-shrink_800/image-shrink_800/0/1715263231761?e=2147483647&v=beta&t=OduMubGyL7Wy_C-wlARcN3azMfssyXHbt8xhW8261IE)
A pivotal 2021 clinical trial of semaglutide showed that participants lost an average of 15% of their body weight over 68 weeks, compared to just 2% in the placebo group
![glp-1 based therapeutics summit 3rd GLP-1-Based 2026 [04/14/26] GLP-1 therapy appears to reduce](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41584-025-01302-0/MediaObjects/41584_2025_1302_Fig1_HTML.png)
Studies have also explored its impact on oxidative stress and inflammation in various biological models
![glp-1 based therapeutics summit 3rd GLP-1-Based 2026 [04/14/26] GLP-1 therapy appears to reduce](http://summitnutritions.com/cdn/shop/collections/Glp_-1_total_support_hero_Image_mobile_webp.webp?v=1776432844)
McLaughlin SA, Wright MJ, Morris KT, Giron GL, Sampson MR, Brockway JP, et al
![glp-1 based therapeutics summit 3rd GLP-1-Based 2026 [04/14/26] GLP-1 therapy appears to reduce](https://pharmaphorum.com/sites/default/files/2024-02/Main-Image.jpg)
